HUP0004747A3 - 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinoline derivatives and process for their preparation - Google Patents

4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinoline derivatives and process for their preparation

Info

Publication number
HUP0004747A3
HUP0004747A3 HU0004747A HUP0004747A HUP0004747A3 HU P0004747 A3 HUP0004747 A3 HU P0004747A3 HU 0004747 A HU0004747 A HU 0004747A HU P0004747 A HUP0004747 A HU P0004747A HU P0004747 A3 HUP0004747 A3 HU P0004747A3
Authority
HU
Hungary
Prior art keywords
carboxyamino
substituted
preparation
tetrahydroquinoline derivatives
tetrahydroquinoline
Prior art date
Application number
HU0004747A
Other languages
English (en)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of HU0004747D0 publication Critical patent/HU0004747D0/hu
Publication of HUP0004747A2 publication Critical patent/HUP0004747A2/hu
Publication of HUP0004747A3 publication Critical patent/HUP0004747A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HU0004747A 1999-11-30 2000-11-29 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinoline derivatives and process for their preparation HUP0004747A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16796799P 1999-11-30 1999-11-30

Publications (3)

Publication Number Publication Date
HU0004747D0 HU0004747D0 (hu) 2001-02-28
HUP0004747A2 HUP0004747A2 (hu) 2001-10-28
HUP0004747A3 true HUP0004747A3 (en) 2002-12-28

Family

ID=22609556

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0004747A HUP0004747A3 (en) 1999-11-30 2000-11-29 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinoline derivatives and process for their preparation

Country Status (45)

Country Link
US (1) US6313142B1 (hu)
EP (1) EP1125929B1 (hu)
JP (1) JP3579345B2 (hu)
KR (1) KR100408177B1 (hu)
CN (1) CN1173953C (hu)
AP (1) AP2000002011A0 (hu)
AR (1) AR029775A1 (hu)
AT (1) ATE315028T1 (hu)
AU (1) AU784694B2 (hu)
BG (1) BG105009A (hu)
BR (1) BR0005636A (hu)
CA (1) CA2327029C (hu)
CO (1) CO5261552A1 (hu)
CY (1) CY1104989T1 (hu)
CZ (1) CZ20004407A3 (hu)
DE (1) DE60025317T2 (hu)
DK (1) DK1125929T3 (hu)
DZ (1) DZ3079A1 (hu)
EA (1) EA003668B1 (hu)
EE (1) EE200000659A (hu)
ES (1) ES2254109T3 (hu)
GE (1) GEP20022798B (hu)
GT (1) GT200000190A (hu)
HK (1) HK1038007A1 (hu)
HN (1) HN2000000203A (hu)
HR (1) HRP20000804A2 (hu)
HU (1) HUP0004747A3 (hu)
ID (1) ID28489A (hu)
IL (1) IL139849A (hu)
IS (1) IS5715A (hu)
MA (1) MA25223A1 (hu)
NO (1) NO20006039L (hu)
NZ (1) NZ508509A (hu)
OA (1) OA11494A (hu)
PA (1) PA8503801A1 (hu)
PE (1) PE20010913A1 (hu)
PL (1) PL344208A1 (hu)
SG (1) SG102603A1 (hu)
SK (1) SK17792000A3 (hu)
TN (1) TNSN00230A1 (hu)
TW (1) TW591016B (hu)
UA (1) UA65615C2 (hu)
UY (1) UY26451A1 (hu)
YU (1) YU71500A (hu)
ZA (1) ZA200006947B (hu)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN2000000203A (es) * 1999-11-30 2001-06-13 Pfizer Prod Inc Procedimiento para la obtencion de 1,2,3,4-tetrahidroquinolinas 4-carboxiamino-2- sustituidas.
US7202247B2 (en) 2001-12-19 2007-04-10 Atherogenics, Inc. 1,3-bis-(substituted-phenyl)-2-propyn-1-ones and their use to treat disorders
IL162533A0 (en) * 2001-12-19 2005-11-20 Atherogenics Inc Chalcone derivatives and their use to treat diseases
US7279297B2 (en) * 2002-04-11 2007-10-09 Roar Holding Llc Ex vivo method for determination of CETP activity and efficacy of heart disease treatment
KR20050055747A (ko) * 2002-10-04 2005-06-13 밀레니엄 파머슈티컬스 인코퍼레이티드 염증 질환 치료용의 ｐｇｄ2 수용체 길항제
US20090181966A1 (en) * 2002-10-04 2009-07-16 Millennium Pharmaceuticals, Inc. PGD2 receptor antagonists for the treatment of inflammatory diseases
US7504508B2 (en) * 2002-10-04 2009-03-17 Millennium Pharmaceuticals, Inc. PGD2 receptor antagonists for the treatment of inflammatory diseases
US7223870B2 (en) 2002-11-01 2007-05-29 Pfizer Inc. Methods for preparing N-arylated oxazolidinones via a copper catalyzed cross coupling reaction
WO2004056727A2 (en) * 2002-12-19 2004-07-08 Atherogenics, Inc. Process of making chalcone derivatives
AU2003283769A1 (en) 2002-12-20 2004-07-14 Pfizer Products Inc. Dosage forms comprising a cetp inhibitor and an hmg-coa reductase inhibitor
US20040132771A1 (en) * 2002-12-20 2004-07-08 Pfizer Inc Compositions of choleseteryl ester transfer protein inhibitors and HMG-CoA reductase inhibitors
JP2006523218A (ja) * 2003-03-04 2006-10-12 高砂香料工業株式会社 光学活性アミン類の製造方法
MXPA05009976A (es) * 2003-03-17 2005-11-04 Japan Tobacco Inc Metodo para incrementar la biodisponibilidad oral del 2-metilpropantioato de s-[2-([[1- 2-etilbutil) ciclohexil] carbonil] amino) fenilo].
EP2289507A1 (en) * 2003-03-17 2011-03-02 Japan Tobacco, Inc. Pharmaceutical compositions of CETP inhibitors
TWI393560B (zh) * 2003-05-02 2013-04-21 Japan Tobacco Inc 包含ｓ-〔２（〔〔１-（２-乙基丁基）環己基〕羰基〕胺基）苯基〕２-甲基丙烷硫酯及ｈｍｇ輔酶ａ還原酶抑制劑之組合
PL1670768T3 (pl) * 2003-10-08 2010-01-29 Lilly Co Eli Związki i sposoby leczenia dyslipidemii
UA90269C2 (ru) * 2004-04-02 2010-04-26 Мицубиси Танабе Фарма Корпорейшн Тетрагидрохинолиновые производные и способ их получения
KR20070041452A (ko) * 2004-06-24 2007-04-18 일라이 릴리 앤드 캄파니 이상지혈증 치료를 위한 화합물 및 방법
DOP2005000123A (es) * 2004-07-02 2011-07-15 Merck Sharp & Dohme Inhibidores de cetp
WO2006033001A1 (en) * 2004-09-23 2006-03-30 Pfizer Products Inc. Quinoline compounds
US7700774B2 (en) * 2004-12-20 2010-04-20 Dr. Reddy's Laboratories Ltd. Heterocyclic compounds and their pharmaceutical compositions
MX2007010215A (es) * 2005-02-24 2007-11-07 Millennium Pharm Inc Antagonistas del receptor pgd2 para el tratamiento de enfermedades inflamatorias.
UY30244A1 (es) 2006-03-30 2007-11-30 Tanabe Seiyaku Co Un proceso para preparar derivados de tetrahidroquinolina
AR065670A1 (es) 2007-03-09 2009-06-24 Indigene Pharmaceuticals Inc Combinacion de metformina r-(+) lipoato y agentes antihiperlipidemicos para el tratamiento de hiperglucemia diabetica y complicaciones diabeticas
CN101429160B (zh) * 2007-11-06 2011-10-19 上海药明康德新药开发有限公司 一种1-r-4-氨基-1,2,3,4-四氢喹啉的合成方法
AR077208A1 (es) * 2009-06-30 2011-08-10 Lilly Co Eli Derivados del acido trans-4-[[(5s)-5-[[[3,5-bis(trifluorometil) fenil] metil] (2-metil-2h-tetrazol-5-il) amino) -2,3,4,5-tetrahidro-7,9-dimetil-1h-1-benzazepin-1-il) metil)-ciclohexancarboxilico y sus formas cristalinas, composiciones farmaceuticas que los comprenden, su uso para preparar un medicam
WO2024009144A1 (en) 2022-07-05 2024-01-11 Newamsterdam Pharma B.V. Salts of obicetrapib and processes for their manufacture and intermediates thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR7870M (hu) * 1968-11-08 1970-04-27
US3971789A (en) 1972-10-21 1976-07-27 John Wyeth & Brother Limited O-(4-Quinolylamino)benzamides
GB8432091D0 (en) 1984-12-19 1985-01-30 Wyeth John & Brother Ltd 4-aminoquinoline derivatives
US4839368A (en) 1986-05-02 1989-06-13 Mochida Pharmaceutical Co., Ltd. 1-acyl-2,3-dihydro-4(1H)-quinolinone-4-oxime derivatives
GB8804444D0 (en) 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
US5231102A (en) 1989-03-08 1993-07-27 Merck Sharp & Dohme, Ltd. Tetrahydroquinoline derivatives useful for neurodegenerative disorders
PT100905A (pt) * 1991-09-30 1994-02-28 Eisai Co Ltd Compostos heterociclicos azotados biciclicos contendo aneis de benzeno, ciclo-hexano ou piridina e de pirimidina, piridina ou imidazol substituidos e composicoes farmaceuticas que os contem
US6140342A (en) 1998-09-17 2000-10-31 Pfizer Inc. Oxy substituted 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines
US6197786B1 (en) * 1998-09-17 2001-03-06 Pfizer Inc 4-Carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines
US6147089A (en) 1998-09-17 2000-11-14 Pfizer Inc. Annulated 4-carboxyamino-2-methyl-1,2,3,4,-tetrahydroquinolines
HN2000000203A (es) * 1999-11-30 2001-06-13 Pfizer Prod Inc Procedimiento para la obtencion de 1,2,3,4-tetrahidroquinolinas 4-carboxiamino-2- sustituidas.

Also Published As

Publication number Publication date
TNSN00230A1 (fr) 2005-11-10
AU7178900A (en) 2001-05-31
PE20010913A1 (es) 2001-09-10
CO5261552A1 (es) 2003-03-31
AU784694B2 (en) 2006-06-01
DZ3079A1 (fr) 2004-10-24
UA65615C2 (uk) 2004-04-15
BR0005636A (pt) 2001-07-17
ATE315028T1 (de) 2006-02-15
YU71500A (sh) 2003-02-28
HN2000000203A (es) 2001-06-13
US6313142B1 (en) 2001-11-06
UY26451A1 (es) 2001-06-29
GT200000190A (es) 2002-04-27
EP1125929A1 (en) 2001-08-22
CN1173953C (zh) 2004-11-03
TW591016B (en) 2004-06-11
HK1038007A1 (en) 2002-03-01
EE200000659A (et) 2001-08-15
CY1104989T1 (el) 2010-03-03
EA200001129A3 (ru) 2001-10-22
AR029775A1 (es) 2003-07-16
DE60025317T2 (de) 2006-08-03
IS5715A (is) 2001-05-31
DE60025317D1 (de) 2006-03-30
ID28489A (id) 2001-05-31
EP1125929B1 (en) 2006-01-04
CA2327029A1 (en) 2001-05-30
ZA200006947B (en) 2002-05-27
HUP0004747A2 (hu) 2001-10-28
EA200001129A2 (ru) 2001-06-25
NO20006039D0 (no) 2000-11-29
BG105009A (en) 2001-11-30
MA25223A1 (fr) 2001-07-02
GEP20022798B (en) 2002-09-25
HRP20000804A2 (en) 2001-06-30
CA2327029C (en) 2005-08-09
AP2000002011A0 (en) 2000-12-31
CZ20004407A3 (cs) 2002-06-12
DK1125929T3 (da) 2006-04-03
OA11494A (en) 2004-05-07
KR100408177B1 (ko) 2003-12-01
EA003668B1 (ru) 2003-08-28
CN1302800A (zh) 2001-07-11
NZ508509A (en) 2001-06-29
JP2001163859A (ja) 2001-06-19
HU0004747D0 (hu) 2001-02-28
NO20006039L (no) 2001-05-31
PA8503801A1 (es) 2002-07-30
SG102603A1 (en) 2004-03-26
IL139849A0 (en) 2002-02-10
SK17792000A3 (sk) 2002-10-08
IL139849A (en) 2006-10-31
KR20010052012A (ko) 2001-06-25
ES2254109T3 (es) 2006-06-16
JP3579345B2 (ja) 2004-10-20
PL344208A1 (en) 2001-06-04

Similar Documents

Publication Publication Date Title
HUP0004747A3 (en) 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinoline derivatives and process for their preparation
HUP0203425A3 (en) Quinazoline derivatives, process for their preparation and their use
IL147923A0 (en) 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents
IL147925A0 (en) 3(5)-ureido-pyrazole derivatives, process for their preparation and their use as antitumor agents
HUP0201225A3 (en) 4,5,6,7-tetrahydroindazole derivatives as antitumor agent and process for their preparation
HUP0102084A3 (en) Quinoline derivatives, process for producing them and pharmaceutical compositions containing them
HUP0103224A3 (en) Quinoline derivatives, process for producing them and pharmaceutical compositions containing them
HK1046681A1 (en) 6-alkenyl-, 6-alkinyl- and 6-epoxy-epothilone derivatives, process for their production, and their use
IL143859A0 (en) 1,2-annelated quinoline derivatives
GB9823873D0 (en) 2-ureido-thiazole derivatives,process for their preparation,and their use as antitumour agents
HUP0105136A3 (en) Amide derivatives, process for their preparation and medicaments containing them
HUP9800555A3 (en) 3,3-diphenylallylamine derivatives and process for their preparation
HUP0004884A3 (en) Process for preparing 1,4-dihydropyridine derivatives
EP0990632A4 (en) ADAMANTANEMETHANOL DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF
AU7446900A (en) Thioalkylamine derivatives and process for the preparation thereof
HUP0104819A2 (en) Chroman derivatives, their use intermediate and process for their preparation
HUP0101234A3 (en) Betha-carboline derivatives, process for their preparation and pharmaceutical compositions thereof
IL139023A0 (en) Process for the preparation of 2,3,5-trimethyl-p- benzoquinone
HUP0003861A3 (en) Quinolin-4-yl derivatives, process for producing them and pharmaceutical compositions containing them
SI0863139T1 (en) Benzoxazindione derivatives, process for their preparation and their use
AU6870500A (en) Process for the preparation of 2,3-dihydroazepine derivatives
HUP0203421A3 (en) Process for preparing 10,11-methanobenzosuberane derivatives and their intermediates and processes for preparation thereof
AU2942100A (en) Vitamin d derivatives and process for the preparation thereof
SI1175428T1 (en) 3-deoxy-desmycosin derivatives and process for their preparation
AU4143100A (en) Novel bicycloheptene derivatives and process for the preparation thereof

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees